3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
2
Phase NA
1
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
4
Lymphoid
2
Sarcoma
1
Conditions
Lymphoma
2
Sarcoma, Ewing
1
Sarcoma
1
Osteosarcoma
1
Neoplasms
1
Interventions
Cyclophosphamide
26
Rituximab
17
Etoposide
16
Methotrexate
15
Dexamethasone
15
Cytarabine
15
Vincristine
14
Prednisone
11
Doxorubicin
11
Radiotherapy
10
blinatumomab
8
fludarabine
7
Mercaptopurine
7
Filgrastim
7
Daunorubicin
7
Asparaginase
7
pegaspargase
6
Granulocyte Colony-Stimulating Factor
6
Methylprednisolone
5
Drug Therapy
5
Dasatinib
5
venetoclax
4
prednylidene
4
etoposide phosphate
4
deltacortene
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
Busulfan
4
Bendamustine Hydrochloride
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Triptorelin Pamoate
×
Lymphoid
×
Clear all
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled
NCT01160315
2015-10-30
Erasme-POF
Erasme University Hospital
Phase 2/3
Completed
118 enrolled